Eur Rev Med Pharmacol Sci 2016; 20 (14): 2947-2949

Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein

L. Rinaldi, S. Milione, G. Porta, L.I. Siniscalchi, G. Franci, R. Di Francia

Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Second University of Naples, Italy. lucarinaldi@hotmail.it

Free PDF Download

To cite this article

L. Rinaldi, S. Milione, G. Porta, L.I. Siniscalchi, G. Franci, R. Di Francia
Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 14
Pages: 2947-2949

Keywords Related articles:

  1. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein
  2. MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT)
  3. HDAC5 promotes cell proliferation in human hepatocellular carcinoma by up-regulating Six1 expression
  4. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells
  5. The cell death pathway induced by metal halide complexes of pyridine and derivative ligands in hepatocellular carcinoma cells – necrosis or apoptosis?